T842-2400 Screening compound: 3-[3-(2-methoxyethyl)-3H-imidazo[4,5-c]pyridin-2-yl]-N-[4-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide

T842-2400 Screening compound: 3-[3-(2-methoxyethyl)-3H-imidazo[4,5-c]pyridin-2-yl]-N-[4-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide
T842-2400 Screening compound: 3-[3-(2-methoxyethyl)-3H-imidazo[4,5-c]pyridin-2-yl]-N-[4-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T842-2400
3-[3-(2-methoxyethyl)-3H-imidazo[4,5-c]pyridin-2-yl]-N-[4-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T842-2400

Molecular Formula

C21H22F3N5O2 (C21 H22 F3 N5 O2)

Compound Name

3-[3-(2-methoxyethyl)-3H-imidazo[4,5-c]pyridin-2-yl]-N-[4-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide

IUPAC name

3-[3-(2-methoxyethyl)-3H-imidazo[45-c]pyridin-2-yl]-N-[4-(trifluoromethyl)phenyl]pyrrolidine-1-carboxamide

SMILES

COCCn1c(cncc2)c2nc1C(CC1)CN1C(Nc1ccc(C(F)(F)F)cc1)=O

InChI

InChI=1S/C21H22F3N5O2/c1-31-11-10-29-18-12-25-8-6-17(18)27-19(29)14-7-9-28(13-14)20(30)26-16-4-2-15(3-5-16)21(22,23)24/h2-6,8,12,14H,7,9-11,13H2,1H3,(H,26,30)/t14-/m1/s1

InChI Key

CRFBDNDFIYTLDV-CQSZACIVSA-N

MDL Number (MFCD)

MFCD28121831

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

433.43

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.509

Distribution Coefficient, logD

3.509

Water Solubility, LogSw

-3.27

Polar Surface Area

53.774

Acid Dissociation Constant (pKa)

13.81

Base Dissociation Constant (pKb)

4.42

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.10

T842-2400 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

KRAS-Targeted Library (16000 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Targets:
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T842-2400 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T842-2400?
Check Price and Availability of T842-2400, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T842-2400 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T842-2400
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T842-2400
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T842-2400 available by request